Catalyst Pharmaceuticals (CPRX) Receivables - Other (2011)

Catalyst Pharmaceuticals (CPRX) posted Receivables - Other of -$134025.0 for Q1 2011.

Catalyst Pharmaceuticals (CPRX) Receivables - Other (2011) Analysis & Trends

Catalyst Pharmaceuticals' Receivables - Other history runs 1 years deep, the most recent figure standing at -$134025.0 for Q1 2011.

Quarterly Receivables - Other changed N/A year-over-year to -$134025.0 in Q1 2011, while the trailing twelve-month figure through Dec 2011 was -$134025.0 (changed N/A YoY) and the FY2011 annual result came in at -$134025.0, down 200.0% from the prior year.
Receivables - Other was -$134025.0 for Q1 2011 at Catalyst Pharmaceuticals.
Across five years, Receivables - Other topped out at -$134025.0 in Q1 2011 and bottomed at -$134025.0 in Q1 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Catalyst Pharmaceuticals	3.85 Bn	3.09 Bn	134.92 Mn

Historic Data

Download Data

Date	Value
Mar 31, 2011	-134,025.00
Mar 31, 2011	-134,025.00